Category

Clinical Trials

Doctor and patient

Oncopeptides initiates US Expanded Access Program

October 1, 2020

Oncopeptides announces that the open-label …

Dorte X. Gram Photo Jenny Leyman

PILA PHARMA announces positive trial results

September 28, 2020

PILA PHARMA has announced that …

Göran Forsberg, CEO, Cantargia

Cantargia reports new trial results and presents next development steps

September 24, 2020

Cantargia has announced updated interim …

Johan Luthman

Lundbeck announces positive data from the COMPLETE study

September 24, 2020

Lundbeck announces a new study …

Cities changing diabetes Novo Nordisk

Results from the world’s largest study of cardiovascular disease in type 2 diabetes

September 24, 2020

Novo Nordisk has announced the …

Jan van de Winkel

Genmab and Seattle Genetics present new data

September 22, 2020

Genmab and Seattle Genetics has …

Liver

Galecto’s oral galectin-3 Inhibitor well tolerated in Phase 1

September 17, 2020

Galecto’s oral small molecule galectin-3 …

Ron Cooper

Albireo trial meets primary endpoints

September 15, 2020

Albireo Pharma has announced positive …

Mene Pangalos

AstraZeneca announces results from Fasenra trial

September 14, 2020

Results from the OSTRO Phase …

Johan Luthman

Positive results from Lundbeck’s Vyepti study

September 14, 2020

Lundbeck has announced results from …

Renee Aguiar-Lucander

Calliditas enrolls first patient in China in Phase 3 study

September 9, 2020

Calliditas Therapeutics has announced that …

Oncopeptides completes extended enrollment of Phase 3 study

September 8, 2020

Oncopeptides has announced that the …

Hasan

Exact Therapeutics restarts Phase I study

September 8, 2020

Exact Therapeutics has announced that …

Parkinsons disease

Herantis Pharma announces Phase I-II study results

September 1, 2020

Herantis Pharma has announced that …

AstraZeneca research

New results from AstraZeneca’s Farxiga trial

August 31, 2020

Detailed results from the Phase …

Michael Engsig

Vaccibody finalizes patient enrolment in Phase I/IIa trial

August 28, 2020

Vaccibody has reached the enrolment …

1
2
3
4
···
32